Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
NCT06063122
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical study is to test a new, novel medical device designed to improve speech sound differentiation among hospitalized preterm infants. The device is designed to be used at an age equivalent to 32 weeks of gestation or older and to integrate readily into clinical practice for use by nurses and therapists staffing Level II to Level IV NICUs. Preterm born infants are at high risk for neurosensory impairments and developmental delays.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Premature Birth
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 32 to 35 weeks
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Thrive Neuromedical, LLC
- Last updated on ClinicalTrials.gov
- September 10, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Georgia · 1
- Emory University · Atlanta, GA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.